Excerpt:

Pharmaceutical companies face far more regulations and laws than most others and are forced to embrace stricter governance controls to effectively operate and compete on a global scale. These challenges are enhanced by many factors, including merger and acquisition activities and the increasing complexity of the drug discovery and development process. To comply with these demands, life sciences companies are required to deploy information governance practices to enforce desirable behavior in the creation, use, archiving, and disposition of corporate information.